Medicine & TechnologyBy fitting eels with satellites, scientists have tracked the creatures in their last leg of the route. Read to learn more about the mysterious eel migration.
A study reveals that a small portion of oil in the water surface can cause feather loss to the seabirds flying by. Know how it can be detrimental to the birds. Read here now!
Next Science Limited (ASX:NXS) (Next Science / the Company) is pleased to report that XPERIENCETM No Rinse Solution has been shown to have persistent efficacy against both planktonic bacteria and bacterial biofilms in a new study published in The Journal of Arthroplasty.
HMNC Brain Health ("HMNC'' or the "Company"), a global clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, together with Develco Pharma, a company specializing in the development and manufacture of orally administered modified, prolonged & chrono release drugs today announced promising top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release formulation of ketamine (KET01) in Treatment-Resistant Depression (TRD).
Diet products like sodas, yogurt, and cheese containing artificial sweeteners may increase the risk of cancer. Learn more about the study findings here.
When is it Safe to Return to Play After a Concussion? Researchers at Palo Alto University's (PAU) Behavioral Research and Assessment in Neuropsychology (BRAIN) Lab, are compiling data to help families and sports organizations assess when it is safe for student-athletes to return to play after a concussion.
Supplementation with Curcugen® from Dolcas Biotech delivered clinically significant improvements in knee pain and performance-based tests in a randomized, double-blind, placebo-controlled study.
A team of researchers at the Massachusetts Institute of Technology recently developed a new approach for extracting methane from the air with the use of an affordable, common clay type, usually used for cat litter.
Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) annual meeting, in Orlando, Florida, on Jan.13-15, 2022. More than 20 abstracts have been accepted, including three late-breaking presentations.